Tamoxifen Citrate 20Mg Tab

DRUG2 trials

Sponsors

Queen Mary University of London, Azienda Ospedaliera Universitaria Integrata Verona

Conditions

Breast CancerCystic Fibrosis - Complete

Phase 2

Early Study on Tamoxifen Safety/Tolerability in Cystic Fibrosis Patients Unable to Use CFTR Modulators.

Not yet recruitingNCT07289035

Azienda Ospedaliera Universitaria Integrata VeronaCystic Fibrosis - Complete

Start: 2026-01-15End: 2027-02-01Target: 35Updated: 2025-12-17

Phase 3

Tamoxifen for the Prevention of Breast Cancer in High-Risk Women

CompletedNCT00002644

Queen Mary University of LondonBreast Cancer

Start: 1994-01-31End: 2011-03-30Updated: 2024-12-11